October 2017

The use of oral oncolytic agents is on the rise, and these medications now account for a large percentage of all prescribed cancer treatments. Although oral agents offer a convenient alternative to traditional intravenous (IV) chemotherapy, they present new and unique challenges to caregivers.

Use of social media can easily violate patient confidentiality.

A process-based approach pulls together the components of care, ensuring a smoother journey for patients.

Seasoned nurses know the ins and outs of the job, therefore they can be the best resource for those who are just beginning their career.

Strong interdisciplinary relationships between healthcare providers, specifically pharmacy and nursing, can play a crucial role in patient success with oral chemotherapy regimens.

Although it is estimated that malignant mesothelioma represents less than 1% of all cancers, it is a fatal asbestos-associated malignancy, and patients with MPM tend to be difficult to treat.

Incidence evaluated at 11 National Cancer Institute–designated cancer centers reveals more about occurrence in day-to-day clinical practice.

Discoveries are made every day in the treatment of cancer. Fortunately, many are now in the form of oral drugs, which offer convenience to patients, who can take them from the comfort of their home instead of having to travel to a cancer center. But that easy accessibility comes with a cost: nonadherence.